figshare
Browse
pone.0251957.s002.pdf (3.21 MB)

Clonogenic assay.

Download (3.21 MB)
journal contribution
posted on 2021-11-03, 17:24 authored by Riccardo Serra, Tianna Zhao, Sakibul Huq, Noah Leviton Gorelick, Joshua Casaos, Arba Cecia, Antonella Mangraviti, Charles Eberhart, Renyuan Bai, Alessandro Olivi, Henry Brem, Eric M. Jackson, Betty Tyler

ONS76 and UW228 clonogenic potential is significantly reduced by 7 days of combination therapy with DSF-Cu++ 150nM.

(PDF)

History

Usage metrics

    PLOS ONE

    Categories

    Keywords

    sup >+sup >++common brain malignancytp53m ), d425mednpl4 ), ki67combination may servegroup 3 mbcancer stem cellsnpl4 accumulationgroup 3xlink ">vivo vitro ubiquitylated proteinsstill responsiblenovel treatmentneun expressionnanomolar concentrationsmolecular mechanismshuman sshfollowing treatmentexisting therapiesdsf ),dna damagedata suggestclonogenic assaysapproved inhibitoraldh ),aggressive subtypes

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC